nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.135	0.234	CbGbCtD
Sitagliptin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0952	0.165	CbGbCtD
Sitagliptin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0643	0.111	CbGbCtD
Sitagliptin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0614	0.106	CbGbCtD
Sitagliptin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0547	0.0948	CbGbCtD
Sitagliptin—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0536	0.0928	CbGbCtD
Sitagliptin—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0506	0.0877	CbGbCtD
Sitagliptin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0321	0.0556	CbGbCtD
Sitagliptin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0303	0.0525	CbGbCtD
Sitagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—LEP—chronic obstructive pulmonary disease	0.00261	0.063	CbGpPWpGaD
Sitagliptin—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00257	0.062	CbGpPWpGaD
Sitagliptin—DPP4—Incretin synthesis, secretion, and inactivation—LEP—chronic obstructive pulmonary disease	0.00232	0.056	CbGpPWpGaD
Sitagliptin—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00227	0.0548	CbGpPWpGaD
Sitagliptin—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00186	0.0448	CbGpPWpGaD
Sitagliptin—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00158	0.0381	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00147	0.0354	CbGpPWpGaD
Sitagliptin—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00144	0.0347	CbGpPWpGaD
Sitagliptin—DPP4—Peptide hormone metabolism—ACE—chronic obstructive pulmonary disease	0.00127	0.0306	CbGpPWpGaD
Sitagliptin—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00115	0.0277	CbGpPWpGaD
Sitagliptin—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00104	0.0252	CbGpPWpGaD
Sitagliptin—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000943	0.0228	CbGpPWpGaD
Sitagliptin—DPP4—Peptide hormone metabolism—LEP—chronic obstructive pulmonary disease	0.000786	0.019	CbGpPWpGaD
Sitagliptin—CYP2C8—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000758	0.0183	CbGpPWpGaD
Sitagliptin—CYP2C8—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000729	0.0176	CbGpPWpGaD
Sitagliptin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000723	0.0175	CbGpPWpGaD
Sitagliptin—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000635	0.00166	CcSEcCtD
Sitagliptin—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000633	0.00166	CcSEcCtD
Sitagliptin—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000633	0.00166	CcSEcCtD
Sitagliptin—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000629	0.00165	CcSEcCtD
Sitagliptin—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000629	0.00165	CcSEcCtD
Sitagliptin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000625	0.00164	CcSEcCtD
Sitagliptin—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000622	0.00163	CcSEcCtD
Sitagliptin—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000618	0.00162	CcSEcCtD
Sitagliptin—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000618	0.00162	CcSEcCtD
Sitagliptin—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000616	0.00161	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.00061	0.0147	CbGpPWpGaD
Sitagliptin—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00061	0.0016	CcSEcCtD
Sitagliptin—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000609	0.0016	CcSEcCtD
Sitagliptin—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000607	0.00159	CcSEcCtD
Sitagliptin—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000607	0.00159	CcSEcCtD
Sitagliptin—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000606	0.00159	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000603	0.00158	CcSEcCtD
Sitagliptin—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.0006	0.00157	CcSEcCtD
Sitagliptin—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000598	0.00157	CcSEcCtD
Sitagliptin—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000598	0.00157	CcSEcCtD
Sitagliptin—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000598	0.00157	CcSEcCtD
Sitagliptin—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000598	0.00157	CcSEcCtD
Sitagliptin—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000594	0.00156	CcSEcCtD
Sitagliptin—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00059	0.00155	CcSEcCtD
Sitagliptin—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00059	0.00155	CcSEcCtD
Sitagliptin—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.000588	0.00154	CcSEcCtD
Sitagliptin—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000586	0.00153	CcSEcCtD
Sitagliptin—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000582	0.00153	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000574	0.0015	CcSEcCtD
Sitagliptin—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000573	0.0015	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000571	0.0015	CcSEcCtD
Sitagliptin—Cough—Formoterol—chronic obstructive pulmonary disease	0.000571	0.0015	CcSEcCtD
Sitagliptin—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000571	0.0015	CcSEcCtD
Sitagliptin—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000566	0.00148	CcSEcCtD
Sitagliptin—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000565	0.00148	CcSEcCtD
Sitagliptin—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000565	0.00148	CcSEcCtD
Sitagliptin—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000564	0.00148	CcSEcCtD
Sitagliptin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00056	0.0135	CbGpPWpGaD
Sitagliptin—Cough—Montelukast—chronic obstructive pulmonary disease	0.000559	0.00147	CcSEcCtD
Sitagliptin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000557	0.00146	CcSEcCtD
Sitagliptin—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000557	0.00146	CcSEcCtD
Sitagliptin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000557	0.00146	CcSEcCtD
Sitagliptin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000557	0.00146	CcSEcCtD
Sitagliptin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000557	0.00146	CcSEcCtD
Sitagliptin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000557	0.00146	CcSEcCtD
Sitagliptin—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000555	0.00145	CcSEcCtD
Sitagliptin—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000555	0.00145	CcSEcCtD
Sitagliptin—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000555	0.00145	CcSEcCtD
Sitagliptin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000555	0.00145	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000553	0.00145	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000553	0.00145	CcSEcCtD
Sitagliptin—CYP2C8—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000551	0.0133	CbGpPWpGaD
Sitagliptin—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00055	0.00144	CcSEcCtD
Sitagliptin—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00055	0.00144	CcSEcCtD
Sitagliptin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000546	0.00143	CcSEcCtD
Sitagliptin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000546	0.00143	CcSEcCtD
Sitagliptin—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000545	0.00143	CcSEcCtD
Sitagliptin—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000545	0.00143	CcSEcCtD
Sitagliptin—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000544	0.00142	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000542	0.00142	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000541	0.00142	CcSEcCtD
Sitagliptin—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000539	0.00141	CcSEcCtD
Sitagliptin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000534	0.0014	CcSEcCtD
Sitagliptin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000534	0.0014	CcSEcCtD
Sitagliptin—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000533	0.0014	CcSEcCtD
Sitagliptin—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00053	0.00139	CcSEcCtD
Sitagliptin—Infection—Formoterol—chronic obstructive pulmonary disease	0.00053	0.00139	CcSEcCtD
Sitagliptin—CYP2C8—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00053	0.0128	CbGpPWpGaD
Sitagliptin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000526	0.00138	CcSEcCtD
Sitagliptin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000526	0.00138	CcSEcCtD
Sitagliptin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000526	0.00138	CcSEcCtD
Sitagliptin—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000524	0.00137	CcSEcCtD
Sitagliptin—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000524	0.00137	CcSEcCtD
Sitagliptin—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000524	0.00137	CcSEcCtD
Sitagliptin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000523	0.00137	CcSEcCtD
Sitagliptin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000523	0.00137	CcSEcCtD
Sitagliptin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00052	0.00136	CcSEcCtD
Sitagliptin—Infection—Montelukast—chronic obstructive pulmonary disease	0.00052	0.00136	CcSEcCtD
Sitagliptin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000519	0.00136	CcSEcCtD
Sitagliptin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000519	0.00136	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000519	0.0125	CbGpPWpGaD
Sitagliptin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000517	0.00135	CcSEcCtD
Sitagliptin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000514	0.00135	CcSEcCtD
Sitagliptin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000513	0.00134	CcSEcCtD
Sitagliptin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000508	0.00133	CcSEcCtD
Sitagliptin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000504	0.00132	CcSEcCtD
Sitagliptin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000501	0.00131	CcSEcCtD
Sitagliptin—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000499	0.00131	CcSEcCtD
Sitagliptin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000494	0.0013	CcSEcCtD
Sitagliptin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00049	0.00128	CcSEcCtD
Sitagliptin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000487	0.00128	CcSEcCtD
Sitagliptin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000487	0.0118	CbGpPWpGaD
Sitagliptin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000486	0.00127	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000486	0.00127	CcSEcCtD
Sitagliptin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000483	0.00127	CcSEcCtD
Sitagliptin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000483	0.00127	CcSEcCtD
Sitagliptin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00048	0.00126	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000476	0.00125	CcSEcCtD
Sitagliptin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000475	0.00124	CcSEcCtD
Sitagliptin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000475	0.00124	CcSEcCtD
Sitagliptin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000473	0.00124	CcSEcCtD
Sitagliptin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00047	0.00123	CcSEcCtD
Sitagliptin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00047	0.00123	CcSEcCtD
Sitagliptin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000465	0.00122	CcSEcCtD
Sitagliptin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000464	0.00122	CcSEcCtD
Sitagliptin—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000463	0.00121	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000461	0.00121	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000461	0.00121	CcSEcCtD
Sitagliptin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00046	0.00121	CcSEcCtD
Sitagliptin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00046	0.00121	CcSEcCtD
Sitagliptin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00046	0.00121	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000459	0.0012	CcSEcCtD
Sitagliptin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000457	0.0012	CcSEcCtD
Sitagliptin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000457	0.0012	CcSEcCtD
Sitagliptin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000457	0.0012	CcSEcCtD
Sitagliptin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000457	0.0012	CcSEcCtD
Sitagliptin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000456	0.0012	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000452	0.00118	CcSEcCtD
Sitagliptin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000451	0.00118	CcSEcCtD
Sitagliptin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00117	CcSEcCtD
Sitagliptin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000447	0.00117	CcSEcCtD
Sitagliptin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000446	0.00117	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000444	0.00116	CcSEcCtD
Sitagliptin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.00116	CcSEcCtD
Sitagliptin—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000443	0.0107	CbGpPWpGaD
Sitagliptin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000442	0.00116	CcSEcCtD
Sitagliptin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000442	0.00116	CcSEcCtD
Sitagliptin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00044	0.00115	CcSEcCtD
Sitagliptin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00044	0.00115	CcSEcCtD
Sitagliptin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00044	0.00115	CcSEcCtD
Sitagliptin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.00115	CcSEcCtD
Sitagliptin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000438	0.00115	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000437	0.00114	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000437	0.00114	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000435	0.00114	CcSEcCtD
Sitagliptin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000435	0.00114	CcSEcCtD
Sitagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000432	0.0104	CbGpPWpGaD
Sitagliptin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000431	0.00113	CcSEcCtD
Sitagliptin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000431	0.00113	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000428	0.00112	CcSEcCtD
Sitagliptin—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000428	0.00112	CcSEcCtD
Sitagliptin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000424	0.00111	CcSEcCtD
Sitagliptin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000424	0.00111	CcSEcCtD
Sitagliptin—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000424	0.0102	CbGpPWpGaD
Sitagliptin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000422	0.00111	CcSEcCtD
Sitagliptin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000422	0.00111	CcSEcCtD
Sitagliptin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000421	0.0011	CcSEcCtD
Sitagliptin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000417	0.00109	CcSEcCtD
Sitagliptin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000417	0.00109	CcSEcCtD
Sitagliptin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000417	0.00109	CcSEcCtD
Sitagliptin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000415	0.00109	CcSEcCtD
Sitagliptin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000415	0.00109	CcSEcCtD
Sitagliptin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000414	0.00109	CcSEcCtD
Sitagliptin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000413	0.00108	CcSEcCtD
Sitagliptin—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000413	0.00108	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000412	0.00108	CcSEcCtD
Sitagliptin—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000407	0.00983	CbGpPWpGaD
Sitagliptin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000401	0.00105	CcSEcCtD
Sitagliptin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00104	CcSEcCtD
Sitagliptin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000393	0.00103	CcSEcCtD
Sitagliptin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000393	0.00103	CcSEcCtD
Sitagliptin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000393	0.00103	CcSEcCtD
Sitagliptin—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000392	0.00946	CbGpPWpGaD
Sitagliptin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000385	0.00101	CcSEcCtD
Sitagliptin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.001	CcSEcCtD
Sitagliptin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000383	0.001	CcSEcCtD
Sitagliptin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000375	0.000983	CcSEcCtD
Sitagliptin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.000973	CcSEcCtD
Sitagliptin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000365	0.000957	CcSEcCtD
Sitagliptin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000365	0.000957	CcSEcCtD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000364	0.0088	CbGpPWpGaD
Sitagliptin—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000362	0.000949	CcSEcCtD
Sitagliptin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.000948	CcSEcCtD
Sitagliptin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000358	0.000938	CcSEcCtD
Sitagliptin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000354	0.00854	CbGpPWpGaD
Sitagliptin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000353	0.000925	CcSEcCtD
Sitagliptin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000353	0.000925	CcSEcCtD
Sitagliptin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000346	0.000906	CcSEcCtD
Sitagliptin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.000904	CcSEcCtD
Sitagliptin—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.00034	0.000892	CcSEcCtD
Sitagliptin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000339	0.00089	CcSEcCtD
Sitagliptin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.00089	CcSEcCtD
Sitagliptin—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000339	0.0082	CbGpPWpGaD
Sitagliptin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000337	0.000882	CcSEcCtD
Sitagliptin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000337	0.000882	CcSEcCtD
Sitagliptin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000336	0.000881	CcSEcCtD
Sitagliptin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.000881	CcSEcCtD
Sitagliptin—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000336	0.000881	CcSEcCtD
Sitagliptin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000335	0.000877	CcSEcCtD
Sitagliptin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.000877	CcSEcCtD
Sitagliptin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000334	0.000875	CcSEcCtD
Sitagliptin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000333	0.000874	CcSEcCtD
Sitagliptin—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000333	0.000874	CcSEcCtD
Sitagliptin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000333	0.000871	CcSEcCtD
Sitagliptin—Rash—Montelukast—chronic obstructive pulmonary disease	0.00033	0.000864	CcSEcCtD
Sitagliptin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000329	0.000863	CcSEcCtD
Sitagliptin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000329	0.000862	CcSEcCtD
Sitagliptin—Depression—Prednisone—chronic obstructive pulmonary disease	0.000329	0.000861	CcSEcCtD
Sitagliptin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000328	0.000859	CcSEcCtD
Sitagliptin—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000324	0.000848	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000323	0.000846	CcSEcCtD
Sitagliptin—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000322	0.00778	CbGpPWpGaD
Sitagliptin—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000322	0.00777	CbGpPWpGaD
Sitagliptin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.00084	CcSEcCtD
Sitagliptin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00032	0.000837	CcSEcCtD
Sitagliptin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000318	0.000834	CcSEcCtD
Sitagliptin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.000833	CcSEcCtD
Sitagliptin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.000832	CcSEcCtD
Sitagliptin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000317	0.000831	CcSEcCtD
Sitagliptin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000317	0.000831	CcSEcCtD
Sitagliptin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.000828	CcSEcCtD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000315	0.00761	CbGpPWpGaD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000311	0.00751	CbGpPWpGaD
Sitagliptin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000311	0.000814	CcSEcCtD
Sitagliptin—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000306	0.000802	CcSEcCtD
Sitagliptin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.000785	CcSEcCtD
Sitagliptin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000298	0.000781	CcSEcCtD
Sitagliptin—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000296	0.00714	CbGpPWpGaD
Sitagliptin—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000291	0.000762	CcSEcCtD
Sitagliptin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000289	0.000758	CcSEcCtD
Sitagliptin—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000284	0.00687	CbGpPWpGaD
Sitagliptin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000276	0.000724	CcSEcCtD
Sitagliptin—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.00027	0.00651	CbGpPWpGaD
Sitagliptin—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000268	0.000703	CcSEcCtD
Sitagliptin—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000267	0.0007	CcSEcCtD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000266	0.00643	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000265	0.00639	CbGpPWpGaD
Sitagliptin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000262	0.000685	CcSEcCtD
Sitagliptin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000259	0.000679	CcSEcCtD
Sitagliptin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000257	0.000675	CcSEcCtD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000255	0.00617	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000248	0.006	CbGpPWpGaD
Sitagliptin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000247	0.000648	CcSEcCtD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000246	0.00594	CbGpPWpGaD
Sitagliptin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000243	0.000636	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000239	0.00577	CbGpPWpGaD
Sitagliptin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000239	0.000626	CcSEcCtD
Sitagliptin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000238	0.000624	CcSEcCtD
Sitagliptin—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000235	0.000617	CcSEcCtD
Sitagliptin—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000232	0.000608	CcSEcCtD
Sitagliptin—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000231	0.000606	CcSEcCtD
Sitagliptin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00023	0.000602	CcSEcCtD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000229	0.00553	CbGpPWpGaD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000226	0.00545	CbGpPWpGaD
Sitagliptin—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000222	0.000583	CcSEcCtD
Sitagliptin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000574	CcSEcCtD
Sitagliptin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000574	CcSEcCtD
Sitagliptin—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000572	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000218	0.00057	CcSEcCtD
Sitagliptin—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000217	0.000568	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000215	0.00519	CbGpPWpGaD
Sitagliptin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.000558	CcSEcCtD
Sitagliptin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00021	0.000551	CcSEcCtD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000209	0.00505	CbGpPWpGaD
Sitagliptin—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000209	0.00505	CbGpPWpGaD
Sitagliptin—Infection—Prednisone—chronic obstructive pulmonary disease	0.000209	0.000547	CcSEcCtD
Sitagliptin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00054	CcSEcCtD
Sitagliptin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000535	CcSEcCtD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000197	0.00476	CbGpPWpGaD
Sitagliptin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000502	CcSEcCtD
Sitagliptin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.000501	CcSEcCtD
Sitagliptin—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000498	CcSEcCtD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000186	0.00448	CbGpPWpGaD
Sitagliptin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000485	CcSEcCtD
Sitagliptin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000479	CcSEcCtD
Sitagliptin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.000478	CcSEcCtD
Sitagliptin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.000477	CcSEcCtD
Sitagliptin—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000475	CcSEcCtD
Sitagliptin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.000475	CcSEcCtD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000181	0.00437	CbGpPWpGaD
Sitagliptin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00018	0.000471	CcSEcCtD
Sitagliptin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000454	CcSEcCtD
Sitagliptin—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000173	0.00418	CbGpPWpGaD
Sitagliptin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000172	0.00045	CcSEcCtD
Sitagliptin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.00045	CcSEcCtD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000169	0.00408	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000169	0.00408	CbGpPWpGaD
Sitagliptin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000437	CcSEcCtD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000167	0.00403	CbGpPWpGaD
Sitagliptin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000435	CcSEcCtD
Sitagliptin—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000163	0.00394	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000161	0.0039	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000161	0.00389	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.00016	0.00387	CbGpPWpGaD
Sitagliptin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000406	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.000153	0.00371	CbGpPWpGaD
Sitagliptin—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000152	0.00367	CbGpPWpGaD
Sitagliptin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000395	CcSEcCtD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000149	0.00361	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000148	0.00359	CbGpPWpGaD
Sitagliptin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000377	CcSEcCtD
Sitagliptin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000364	CcSEcCtD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000137	0.00331	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000136	0.00328	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000134	0.00323	CbGpPWpGaD
Sitagliptin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000134	0.00035	CcSEcCtD
Sitagliptin—Rash—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000347	CcSEcCtD
Sitagliptin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000347	CcSEcCtD
Sitagliptin—Headache—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000345	CcSEcCtD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000126	0.00304	CbGpPWpGaD
Sitagliptin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000327	CcSEcCtD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000123	0.00297	CbGpPWpGaD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.00293	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000115	0.00277	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000113	0.00273	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000112	0.00269	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000104	0.00251	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000103	0.00248	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.96e-05	0.0024	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	9.87e-05	0.00238	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.85e-05	0.00238	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.72e-05	0.00235	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	9.23e-05	0.00223	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	8.85e-05	0.00214	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.76e-05	0.00212	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.66e-05	0.00209	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	8.65e-05	0.00209	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	7.93e-05	0.00191	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	7.49e-05	0.00181	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.28e-05	0.00176	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.18e-05	0.00173	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	6.91e-05	0.00167	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	6.88e-05	0.00166	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	6.42e-05	0.00155	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.07e-05	0.00147	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.99e-05	0.00145	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.65e-05	0.00137	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.58e-05	0.00135	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.5e-05	0.00133	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.29e-05	0.00128	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.25e-05	0.00127	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.22e-05	0.00126	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.21e-05	0.00126	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	5.11e-05	0.00123	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.75e-05	0.00115	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.58e-05	0.0011	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	4.45e-05	0.00107	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.26e-05	0.00103	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.14e-05	0.000999	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.78e-05	0.000914	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.7e-05	0.000893	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.55e-05	0.000857	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.39e-05	0.00082	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.33e-05	0.000804	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.17e-05	0.000765	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.82e-05	0.000681	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.79e-05	0.000675	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.79e-05	0.000674	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	2.76e-05	0.000666	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.74e-05	0.000662	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.57e-05	0.000621	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.55e-05	0.000616	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.52e-05	0.000608	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.43e-05	0.000587	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.4e-05	0.00058	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.32e-05	0.00056	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.19e-05	0.00053	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.13e-05	0.000515	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.02e-05	0.000488	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.93e-05	0.000467	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.91e-05	0.000461	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.78e-05	0.000429	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.69e-05	0.000407	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.69e-05	0.000407	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.66e-05	0.000401	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.55e-05	0.000374	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.5e-05	0.000362	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.48e-05	0.000358	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.47e-05	0.000355	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.35e-05	0.000326	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.24e-05	0.000301	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.15e-05	0.000277	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.1e-05	0.000265	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.04e-05	0.000251	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.02e-05	0.000247	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	9.98e-06	0.000241	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.55e-06	0.000231	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.54e-06	0.00023	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.05e-06	0.000218	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.15e-06	0.000148	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.88e-06	0.000142	CbGpPWpGaD
